|drug1086||Drug COVID19-0001-USR Wiki||1.00|
|drug3971||normal saline Wiki||1.00|
|D003141||Communicable Diseases NIH||0.07|
There is one clinical trial.
The current COVID-19 pandemic has brought many challenges with implications for wellbeing and mental health. The Southampton Women's Survey provides the opportunity to understand influences on these important outcomes amongst women and their offspring in the context of an established longitudinal cohort study.
Description: General Health Questionnaire (GHQ-12) - higher score more severe conditionMeasure: Mental Health in women Time: 3 months
Description: Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) - higher score describes better mental healthMeasure: Mental Health in offspring Time: 3 months
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports